Dr Bret Rice Haymore, MD | |
4716 W Urbana St, Suite 211, Broken Arrow, OK 74012-5997 | |
(918) 994-5200 | |
(918) 994-5222 |
Full Name | Dr Bret Rice Haymore |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 22 Years |
Location | 4716 W Urbana St, Broken Arrow, Oklahoma |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376503102 | NPI | - | NPPES |
200424280A | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 28286 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oklahoma Allergy And Asthma Clinic | 5294710927 | 12 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Entity Name | Oklahoma Allergy & Asthma Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861599094 PECOS PAC ID: 5294710927 Enrollment ID: O20040618000611 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Entity Name | Hospital Care Consultants Region Ii Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558491449 PECOS PAC ID: 8820197064 Enrollment ID: O20070727000300 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Entity Name | Hcc Duncan Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013153543 PECOS PAC ID: 1759447873 Enrollment ID: O20090225000497 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Entity Name | Heartland Travel Health Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013277979 PECOS PAC ID: 0345476776 Enrollment ID: O20131113001412 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Bret Rice Haymore, MD 8121 National Ave, Ste 309, Midwest City, OK 73110-7572 Ph: (405) 628-3666 | Dr Bret Rice Haymore, MD 4716 W Urbana St, Suite 211, Broken Arrow, OK 74012-5997 Ph: (918) 994-5200 |
News Archive
The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.
Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.
ECFC, the leading nonprofit organization promoting choice in benefit solutions, applauds the proposed regulations from the U.S. Departments of the Treasury, Health and Human Services, and Labor regarding expanding the use of health reimbursement arrangements by employers.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Mark Steven Hamra, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 817 S Elm Pl, Ste 107, Broken Arrow, OK 74012 Phone: 918-259-3141 Fax: 918-258-1266 |